The influence of inhibition of the epidermal growth factor receptor on tympanic membrane wound healing in rats

References

• Amoils CP, Jackler RK, Milczuk H, Kelly KE. 1992. An animal model of chronic tympanic membrane perforation. Otolaryngol Head Neck Surg. 106:47–55.
   PubMed Web of Science ®Google Scholar
• Bianchini D, Jayanth A, Chua YJ, Cunningham D. 2008. Epidermal growth factor receptor inhibitor-related skin toxicity: Mechanisms, treatment, and its potential role as a predictive marker. Clin Colorectal Cancer. 7:33–43.
   PubMed Web of Science ®Google Scholar
• Clymer MA, Schwaber MK, Davidson JM. 1996. The effects of keratinocyte growth factor on healing of tympanic membrane perforations. Laryngoscope. 106:280–285.
   PubMedGoogle Scholar
• Curran D, Giralt J, Harari PM, Ang K, Cohen RB, Kies MS, Jassem J, Baselga J, Rowinsky EK, Amellal N, Comte S, Bonner JA. 2007. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 25:2191–2197.
   PubMed Web of Science ®Google Scholar
• Dvorak DW, Abbas G, Ali T, Stevenson S, Welling B. 1995. Repair of chronic tympanic membrane perforations with long-term epidermal growth factor. Laryngoscope. 105:1300–1304.
   PubMed Web of Science ®Google Scholar
• Fina M, Baird A, Ryan A. 1993. Direct application of basic fibroblast growth factor improves tympanic membrane perforation healing. Laryngoscope. 103:804–809.
   PubMedGoogle Scholar
• Govindan R, Behnken D, Read W, McLeod H. 2003. Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib. Ann Oncol. 14:1330–1331.
   PubMedGoogle Scholar
• Hapgood J, Libermann TA, Lax I, Yarden Y, Schreiber AB, Naor Z, Schlessinger J. 1983. Monoclonal antibodies against epidermal growth factor receptor induce prolactin synthesis in cultured rat pituitary cells (GH3). Proc Natl Acad Sci USA. 80:6451–6455.
   PubMedGoogle Scholar
• Herbst RS, Sandler A. 2008. Bevacizumab and erlotinib: A promising new approach to the treatment of advanced NSCLC. Oncologist. 13:1166–1176.
   PubMedGoogle Scholar
• Hidalgo M, Siu LL, Nemunaitis J, Rizzo J, Hammond LA, Takimoto C, Eckhardt SG, Tolcher A, Britten CD, Denis L, Ferrante K, Von Hoff DD, Silberman S, Rowinsky EK. 2001. Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. J Clin Oncol. 19:3267–3279.
   PubMed Web of Science ®Google Scholar
• Huether A, Höpfner M, Baradari V, Schuppan D, Scherübl H. 2005. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Biochem Pharmacol. 70:1568–1578.
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Shinogami M, Ishimoto SI, Yoshida K, Kaga K. 1998. Induction of KGF, basic FGF, and TGFα mRNA expression during healing of experimental TM perforations. Acta Otolaryngol. 118:701–704.
   PubMed Web of Science ®Google Scholar
• Jaisinghani VJ, Paparella MM, Schachern PA, Le CT. 1999. Tympanic membrane/middle ear pathologic correlates in chronic otitis media. Laryngoscope. 109:712–716.
   PubMed Web of Science ®Google Scholar
• Jang CH, Song CH, Pak SC. 2003. Effect of exposure to mitomycin C on cultured tympanic membrane fibroblasts. Int J Pediatr Otorhinolaryngol. 67:173–176.
   PubMedGoogle Scholar
• Kaftan H, Hosemann W. 2006. Topical application of mitomycin C before versus after myringotomy: An experimental study. ORL. 68:73–76.
   Google Scholar
• Kaftan H, Hosemann W, Beule A, Junghans D. 2004. An improved animal model for chronic perforation of the tympanic membrane. HNO. 52:714–719.
   PubMedGoogle Scholar
• Kaftan H, Vogelgesang S, Lempas K, Hosemann W, Herzog M. 2007. Inhibition of epidermal growth factor receptor by erlotinib: Wound healing of experimental tympanic membrane perforations. Otol Neurotol. 28:245–249.
   PubMedGoogle Scholar
• Kaftan H, Reuther L, Miehe B, Hosemann W, Herzog M. 2008. Delay of tympanic membrane wound healing in rats with topical application of a tyrosine kinase inhibitor. Wound Repair Regen. 16:364–369.
   PubMed Web of Science ®Google Scholar
• Kristensen S. 1992. Spontaneous healing of traumatic tympanic membrane perforations in man: A century of experience. J Laryngol Otol. 106:1037–1050.
   PubMed Web of Science ®Google Scholar
• Kuijpers W, Peters TA, Tonnaer ELGM. 1999. Nature of the tympanic membrane insertion into the tympanic bone of the rat. Hear Res. 128:80–88.
   PubMedGoogle Scholar
• Lee AJ, Jackler RK, Kato M, Scott NM. 1994. Repair of chronic tympanic membrane perforations using epidermal growth factor: Progress toward clinical application. Am J Otol. 15:10–18.
   PubMedGoogle Scholar
• Lee SM, Buchler T, Joseph T, Lai C. 2008. Bilateral eardrum perforation after long-term treatment with erlotinib. J Clin Oncol. 26:2582–2584.
   PubMedGoogle Scholar
• Lehmann EL. 1998. Nonparametrics—statistical methods based on ranks. Englewood Cliffs, NJ: Prentice Hall. p 156–201.
   Google Scholar
• Lim DJ. 1995. Structure and function of the tympanic membrane: A review. Acta Otorhinolaryngol Belg. 49:101–115.
   PubMedGoogle Scholar
• Mondain M, Renard N, Ryan A. 1995. Neutralizing antibodies against basic fibroblast growth factor influence the healing of traumatic tympanic membrane perforations. ORL. 57:28–32.
   Google Scholar
• Olsen E, Stenfors L. 1993. The behaviour of tympanic membrane perforations in tissue culture: A scanning electron microscopic study. J Laryngol Otol. 107:1106–1109.
   PubMed Web of Science ®Google Scholar
• Pytel D, Sliwinski T, Poplawski T, Ferriola D, Majsterek I. 2009. Tyrosine kinase blockers: New hope for successful cancer therapy. Anticancer Agents Med Chem. 9:66–76.
   PubMed Web of Science ®Google Scholar
• Reijnen CJH, Kuijpers W. 1971. The healing pattern of the drum membrane. Acta Otolaryngol Suppl. 287:1–74.
   PubMedGoogle Scholar
• Repertinger SK, Campagnaro E, Fuhrman J, El-Abaseri T, Yuspa SH, Hansen LA. 2004. EGFR enhances early healing after cutaneous incisional wounding. J Invest Dermatol. 123:982–989.
   PubMed Web of Science ®Google Scholar
• Sadè J. 1993. Atelectatic tympanic membrane: Histologic study. Ann Otol Rhinol Laryngol. 102:712–716.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Roychoudhury A, Roychaudhuri BK. 2009. Tympanoplasty in children. Eur Arch Otorhinolaryngol. 266:627–633.
   PubMed Web of Science ®Google Scholar
• Schmidt SH, Hellström S. 1991. Tympanic membrane structure—new views: A comparative study. ORL. 53:32–36.
   Google Scholar
• Somers T, Goovaerts G, Schelfhout L, Peeters S, Govaerts PJ, Offeciers E. 1998. Growth factors in tympanic membrane perforations. Am J Otol. 19:428–434.
   PubMedGoogle Scholar
• Spandow O, Hellström S. 1993. Animal model for persistent tympanic membrane perforations. Ann Otol Rhinol Laryngol. 102:467–472.
   PubMed Web of Science ®Google Scholar